dexpropranolol hydrochloride

(R)-Propranolol hydrochloride (Dexpropranolol hydrochloride) is the less active enantiomer of the anti-adrenoceptor (β-adrenoceptor) antagonist propranolol. Propranolol is a nonselective β-adrenergic receptor (βAR) antagonist with a high affinity for β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively.

Propranolol hydrochloride is a widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse

rac-Propranolol-D7 is a 2H-labeled Rac-Propranolol. Propranolol (TPL0294) is an effective β-adrenergic receptor (βAR) antagonist that inhibits β1AR and β2AR, used in cardiovascular and metabolic disease research.

Propranolol-[D5] (Standard) is a reference standard of Propranolol-[D5] intended for quantitative analysis, quality control, and related biochemical research applications.

Propranolol hydrochloride (Standard) is the standard substance of Propranolol hydrochloride, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Propranolol hydrochloride is a widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.

Propranolol-D7 hydrochloride is a deuterated isotope marker of Propranolol hydrochloride (TMSM-1966), which can be used for isotope tracing. Propranolol is a non-selective beta-blocker used for hypertension research

(S)-(-)-Propranolol hydrochloride, an adrenergic receptor antagonist, exhibits potential anticancer activity and may enhance the prognosis of burn patients.

Propranolol‑D7 hydrochloride (Standard) is a reference standard of Propranolol‑D7 Hydrochloride intended for quantitative analysis, quality control, and related biochemical research applications

Propranolol-D7 (ring-D7) is a deuterated form of Propranolol (TPL0294) hydrochloride, which is a non-selective β-adrenergic receptor (βAR) antagonist with high affinity for both β1AR and β2AR, having Ki values of 1.8 nM and 0.8 nM, respectively. Propranolol (TPL0294) hydrochloride inhibits the binding of [3H]-DHA to rat brain membrane preparations with an IC50 of 12 nM. It is applicable in research related to hypertension, pheochromocytoma, myocardial infarction, arrhythmia, angina, and hypertrophic cardiomyopathy.